922P EACH: A phase II study evaluating the safety and anti-tumour activity of avelumab and cetuximab in recurrent/metastatic squamous cell carcinomas

por Forster, M., Metcalf, R., Sacco, J., Kong, A., Wheeler, G., Forsyth, S., Bhat, R., Blair, K., Ward, J., Lowe, H., Spanswick, V., Ensell, L., Hartley, J., White, L.
Publicado 2020

P1459: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA (B-NHL), AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) / SMALL...

por Roddie, C., Dias, J., O’Reilly, M., Mitsikakou, M., Charalambous, E., Green, L., Vaughan, M., Agliardi, G., Garcia, J., Lewin, E., Lowdell, M., Marzolini, M., Wood, L., Holmes, H., Ngai, Y., Popova, B., Wilson, W., Kunaseelan, S., Spanswick, V., Lowe, H., Ensell, L., Hartley, J., Domning, S., Morley, S., Marafioti, T., Bloor, A., Irvine, D., Orchard, K., Khwaja, A., Linch, D., Pule, M., Peggs, K.
Publicado 2022

P1460: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA

por Roddie, C., Dias, J., O’Reilly, M., Green, L., Vaughan, M., Agliardi, G., Garcia, J., Lewin, E., Lowdell, M., Mitsikakou, M., Charalambous, E., Hotblack, A., Dreau, H., Marzolini, M., Wood, L., Every-Clayton, C., Lal, A., Ngai, Y., Popova, B., Malhi, A., Kunaseelan, S., Spanswick, V., Lowe, H., Ensell, L., Hartley, J., Domning, S., Thorne, L., Hyare, H., Murphy, P., Linch, D., Fox, C., Peggs, K., Cwynarski, K., Pule, M.
Publicado 2022